- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-264/24: Action brought on 17 May 2024 – Laboratorios Salvat v EUIPO – Acta Farma (Omycol)
ECLI:EU:UNKNOWN:62024TN0264
62024TN0264
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
EN
C series
—
C/2024/4337
15.7.2024
(Case T-264/24)
(C/2024/4337)
Language in which the application was lodged: Spanish
Parties
Applicant: Laboratorios Salvat, SA (Esplugues de Llobregat, Spain) (represented by: J. Güell Serra, lawyer)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: Acta Farma, SL (Alcorcón, Spain)
Details of the proceedings before EUIPO
Applicant for the trade mark at issue: Applicant
Trade mark at issue: Application for EU figurative mark Omycol – Application for registration No 018 685 175
Proceedings before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 March 2024 in Case R 1638/2023-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision in its entirety;
—order EUIPO and the other party to the proceedings before EUIPO to pay the costs.
Plea in law
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
—
ELI: http://data.europa.eu/eli/C/2024/4337/oj
ISSN 1977-091X (electronic edition)
—